TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32749459

Group type: EXPERIMENTAL
Intervention: Intracoronary administration of allogeneic cardiosphere-derived cells (CDCs)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 33316099

Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation using collagenated bovine bone mineral and a resorbable collagen membrane (RP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Spontaneous healing (SH)
Number of subjects: 26
Study: 33126051

Group type: EXPERIMENTAL
Intervention: More precise dosing with 0.5 mg acenocoumarol increments
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional dosing with 1.0 mg acenocoumarol increments
Number of subjects: 80
Study: 35982162

Group type: EXPERIMENTAL
Intervention: Vitamin B12 supplementation (1000 µg cyanocobalamin per day for 12 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vitamin B12 supplementation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 34341098

Group type: EXPERIMENTAL
Intervention: Rare PCSK9/APOB variant carriers
Number of subjects: 13131

Group type: EXPERIMENTAL
Intervention: PCSK9 R46L variant heterozygotes
Number of subjects: 13131

Group type: EXPERIMENTAL
Intervention: PCSK9 R46L variant homozygotes
Number of subjects: 13131

Group type: COMPARATOR
Intervention: Non-carriers
Number of subjects: 13131

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 13131
Study: 32157328

Group type: EXPERIMENTAL
Intervention: Nicotine patch (21 mg)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo patch (0 mg)
Number of subjects: 81
Study: 32672515

Group type: EXPERIMENTAL
Intervention: MINDSTRONG© cognitive‐behavioral skills building program
Number of subjects: 201

Group type: COMPARATOR
Intervention: Attention control program
Number of subjects: 201
Study: 33707426

Group type: EXPERIMENTAL
Intervention: Heavy intervention group (HIG)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Light intervention group (LIG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 60
Study: 35554396

Group type: EXPERIMENTAL
Intervention: Acute Cannabidiol (CBD) 25mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute Cannabidiol (CBD) 50mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acute Cannabidiol (CBD) 200mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0mg CBD)
Number of subjects: 0
Study: 32568136

Group type: EXPERIMENTAL
Intervention: PEEK post
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: PIC post
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: FRC post
Number of subjects: 36
Study: 36305845

Group type: EXPERIMENTAL
Intervention: Online yoga intervention
Number of subjects: 72

Group type: COMPARATOR
Intervention: Podcast control
Number of subjects: 72
Study: 33656064

Group type: EXPERIMENTAL
Intervention: ART restorations using High Viscosity Glass‐ionomer cement (HVGIC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional restorations using resin composite
Number of subjects: 54
Study: 36173237

Group type: EXPERIMENTAL
Intervention: Bionic Pancreas (BP) with insulin aspart or insulin lispro
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Bionic Pancreas (BP)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 165
Study: 35284389

Group type: EXPERIMENTAL
Intervention: Personalized educational and behavioral interventions through the EMPOWER app
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 0
Study: 32248163

Group type: EXPERIMENTAL
Intervention: Antiseptic solution 'Decasan'; probiotic 'BioGaia ProDentis'; immune modulator 'Imupret'
Number of subjects: 0

Group type: COMPARATOR
Intervention: Common treatment scheme (control group)
Number of subjects: 0
Study: 36367997

Group type: EXPERIMENTAL
Intervention: 12 cycles of adjuvant fluorouracil, leucovorin, and oxaliplatin chemotherapy
Number of subjects: 2450

Group type: EXPERIMENTAL
Intervention: Exercising ≥ 9 MET-hours per week after treatment
Number of subjects: 2450

Group type: EXPERIMENTAL
Intervention: BMI ≥ 25
Number of subjects: 2450

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 2450
Study: 33421928

Group type: EXPERIMENTAL
Intervention: Ozone therapy (ozonized rectal insufflation and minor auto haemotherapy) along with standard of care (SOC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 60
Study: 35411007

Group type: EXPERIMENTAL
Intervention: Blended cooking oils rich in omega-3 alpha-linolenic acid and phytonutrients
Number of subjects: 126

Group type: COMPARATOR
Intervention: Refined olive oil
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Oil blend with highest concentration of omega-3 PUFA
Number of subjects: 126
Study: 33415448

Group type: EXPERIMENTAL
Intervention: 14Fr pigtail catheters (PCs)
Number of subjects: 43

Group type: COMPARATOR
Intervention: 28-32Fr chest tubes (CTs)
Number of subjects: 43
Study: 32020853

Group type: EXPERIMENTAL
Intervention: A. konjac extract capsules (5 mg glycosylceramides)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 34699271

Group type: EXPERIMENTAL
Intervention: Transoral surgery (TOS) plus 50 Gy postoperative radiation therapy (RT)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Transoral surgery (TOS) plus 60 Gy postoperative radiation therapy (RT)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Transoral surgery (TOS) plus 66 Gy postoperative radiation therapy (RT) and weekly cisplatin
Number of subjects: 495

Group type: COMPARATOR
Intervention: Observation (no treatment)
Number of subjects: 495
Study: 33140566

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study: 32977232

Group type: EXPERIMENTAL
Intervention: Critical care admission
Number of subjects: 825

Group type: COMPARATOR
Intervention: No critical care admission (Control)
Number of subjects: 825
Study: 35105558

Group type: EXPERIMENTAL
Intervention: Verum acupuncture group
Number of subjects: 330

Group type: COMPARATOR
Intervention: Sham acupuncture group
Number of subjects: 330

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 330
Study: 33940126

Group type: EXPERIMENTAL
Intervention: Acromioplasty
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nonacromioplasty
Number of subjects: 90
Study: 32907900

Group type: EXPERIMENTAL
Intervention: Telemedical lifestyle intervention programme
Number of subjects: 850

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 850
Study: 35691777

Group type: EXPERIMENTAL
Intervention: Hyperoxygenated fatty acids (HFA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extra-virgin olive oil (EVOO)
Number of subjects: 0
Study: 33814051

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 100

Group type: COMPARATOR
Intervention: Orthosis
Number of subjects: 100
Study: 35901049

Group type: EXPERIMENTAL
Intervention: Clean-Cook ethanol stoves used for 156 days
Number of subjects: 324

Group type: COMPARATOR
Intervention: Kerosene/firewood users (control)
Number of subjects: 324
Study: 34797886

Group type: EXPERIMENTAL
Intervention: BPT
Number of subjects: 16

Group type: COMPARATOR
Intervention: BPTbounce
Number of subjects: 16
Study: 32966703

Group type: EXPERIMENTAL
Intervention: Custard
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sponge cake
Number of subjects: 12

Group type: COMPARATOR
Intervention: Pudding
Number of subjects: 12

Group type: COMPARATOR
Intervention: Biscuit
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lutein
Number of subjects: 12
Study: 35855385

Group type: EXPERIMENTAL
Intervention: Problem-solving skills training (one session per week for four weeks)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Self-awareness skills training (one session per week for four weeks)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 105
Study: 33843410

Group type: EXPERIMENTAL
Intervention: Semi-immersive Virtual Reality navigation therapy (vSail-Access®), 30-40 min per day, three times per week for six weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (rehabilitation programmed by the hospital)
Number of subjects: 11
Study: 36878996

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (1200 mg twice daily)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 31
Study: 33682983

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 10 mg/kg daily divided into 2 doses every 12 h
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 40
Study: 35006266

Group type: EXPERIMENTAL
Intervention: Intravenous edaravone
Number of subjects: 324

Group type: COMPARATOR
Intervention: Riluzole only (standard therapy)
Number of subjects: 324
Study: 33495732

Group type: EXPERIMENTAL
Intervention: Clinical exercise trial participation
Number of subjects: 16
Study: 35749997

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) 5 mg/kg
Number of subjects: 198

Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 198
Study: 33954850

Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal treatment (NSPT) in the +PE+RA group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Individuals with RA (with and without PE) compared to controls
Number of subjects: 66
Study: 35709376

Group type: EXPERIMENTAL
Intervention: Budesonide 4 mg suppository
Number of subjects: 577

Group type: COMPARATOR
Intervention: Budesonide 2 mg foam
Number of subjects: 577
Study: 32044205

Group type: EXPERIMENTAL
Intervention: HeartWare LVAD (HVAD)
Number of subjects: 604
Study: 34957959

Group type: EXPERIMENTAL
Intervention: Bimanual mirror therapy (BMT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Unimanual mirror therapy (UMT)
Number of subjects: 28
Study: 36239702

Group type: EXPERIMENTAL
Intervention: Midazolam-Fentanyl (M-F)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Midazolam-Ketamine (M-K)
Number of subjects: 58
Study: 34246483

Group type: EXPERIMENTAL
Intervention: Syndesmosis screw fixation (SS)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Suture button (SB)
Number of subjects: 43
Study: 33586572

Group type: EXPERIMENTAL
Intervention: Extended labor group (at least 1 additional hour in the second stage if undelivered after three hours)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual labor group (expedited delivery after three hours in the second stage)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Extended labor group
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual labor group
Number of subjects: 34
Study: 34021093

Group type: EXPERIMENTAL
Intervention: Head-neck precooling
Number of subjects: 8

Group type: COMPARATOR
Intervention: No head-neck precooling
Number of subjects: 8
Study: 35384302

Group type: EXPERIMENTAL
Intervention: Heartfulness Self-Care program (4-week duration)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (wait-listed)
Number of subjects: 108
Study: 32701637

Group type: EXPERIMENTAL
Intervention: 10‐Hz repetitive transcranial magnetic stimulation to left dorsolateral prefrontal cortex
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study: 32941610

Group type: EXPERIMENTAL
Intervention: Mobilization out of bed immediately after abdominal surgery
Number of subjects: 23
Study: 33297826

Group type: EXPERIMENTAL
Intervention: Complete Decongestive Therapy (CDT) plus exercises
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression Therapy (IPCT) plus exercises
Number of subjects: 33

Group type: COMPARATOR
Intervention: Exercises alone (Control)
Number of subjects: 33
Study: 33027531

Group type: EXPERIMENTAL
Intervention: BPV-BCD
Number of subjects: 78

Group type: COMPARATOR
Intervention: plain BPV
Number of subjects: 78
Study: 36409969

Group type: EXPERIMENTAL
Intervention: CBD oil (100 mg/mL, 0.5 mL once daily to 2 mL three times a day)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: CBD oil
Number of subjects: 144

Group type: COMPARATOR
Intervention: CBD oil and Placebo
Number of subjects: 144
Study: 32483847

Group type: EXPERIMENTAL
Intervention: Prucalopride
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 33287715

Group type: EXPERIMENTAL
Intervention: Conditioned Pain Modulation (CPM)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cognitive Distraction (1-back task)
Number of subjects: 38
Study: 35346273

Group type: EXPERIMENTAL
Intervention: Publications related to ONFH
Number of subjects: 2594

Group type: EXPERIMENTAL
Intervention: Publications from China, USA, and Japan
Number of subjects: 2594

Group type: EXPERIMENTAL
Intervention: Correlation analysis of publications
Number of subjects: 2594

Group type: EXPERIMENTAL
Intervention: Keywords categorized into four clusters
Number of subjects: 2594

Group type: EXPERIMENTAL
Intervention: Research hotspots
Number of subjects: 2594

Group type: EXPERIMENTAL
Intervention: Future research focuses
Number of subjects: 2594
Study: 34447275

Group type: EXPERIMENTAL
Intervention: In-house manikin
Number of subjects: 37

Group type: COMPARATOR
Intervention: Commercial manikin
Number of subjects: 37
Study: 33215652

Group type: EXPERIMENTAL
Intervention: Leaf group (expansion screw with Ni-Ti springs)
Number of subjects: 56

Group type: COMPARATOR
Intervention: RME group (conventional RME screw)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Leaf group
Number of subjects: 56

Group type: COMPARATOR
Intervention: RME group
Number of subjects: 56
Study: 34643020

Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 149

Group type: COMPARATOR
Intervention: Insulin glargine U100
Number of subjects: 149
Study: 33756252

Group type: EXPERIMENTAL
Intervention: PARS intervention (12–15 sessions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 32825020

Group type: EXPERIMENTAL
Intervention: Glo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iqos
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Juul
Number of subjects: 0

Group type: COMPARATOR
Intervention: TCC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glo vs Iqos
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glo vs Juul
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iqos vs Juul
Number of subjects: 0
Study: 35334791

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate/high-fat (LCHF) diet (6/69/25% en carbohydrate/fat/protein)
Number of subjects: 7

Group type: COMPARATOR
Intervention: High-carbohydrate/low-fat (HCLF) diet (57/28/15% en carbohydrate/fat/protein)
Number of subjects: 7
Study: 33166694

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 800 mg on Day 1 followed by 400 mg once weekly for 3 weeks
Number of subjects: 317

Group type: COMPARATOR
Intervention: Control group (no HCQ)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: PEP with HCQ
Number of subjects: 317
Study: 35285904

Group type: EXPERIMENTAL
Intervention: 38% hydrogen peroxide bleaching treatment
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo agent
Number of subjects: 72
Study: 36202320

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee consumption
Number of subjects: 48

Group type: COMPARATOR
Intervention: Decaffeinated coffee consumption
Number of subjects: 48
Study: 32703096

Group type: EXPERIMENTAL
Intervention: Experienced shooters (ES) in High Social Inhibition (Hi SI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novice shooters (NS) in High Social Inhibition (Hi SI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Novice shooters (NSL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Experienced shooters (ESL)
Number of subjects: 0
Study: 32792098

Group type: EXPERIMENTAL
Intervention: Artificial neural network model
Number of subjects: 353
Study: 35441839

Group type: EXPERIMENTAL
Intervention: Dual-energy CT (DECT) (n = 40, 80/Sn150 kV, ref. mAs tube A 91/tube B 61)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dual-energy CT (DECT) (n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single-energy computed tomography (SECT) with TVA (n = 40, ref. mAs 200)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single-energy computed tomography (SECT) with TVA (n = 40)
Number of subjects: 80
Study: 34134048

Group type: EXPERIMENTAL
Intervention: Maternal exposure to carbon monoxide (CO) during pregnancy
Number of subjects: 1288
Study: 36279142

Group type: EXPERIMENTAL
Intervention: Mask group (students instructed to wear their own masks at all times)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Mask group
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group (students not required to wear masks)
Number of subjects: 171
Study: 34531293

Group type: COMPARATOR
Intervention: Conventional Lifestyle Intervention (LI) according to the Diabetes Prevention Program (DPP) protocol
Number of subjects: 1105

Group type: EXPERIMENTAL
Intervention: Intensified Lifestyle Intervention (LI) with doubling of required exercise
Number of subjects: 1105
Study: 34581025

Group type: EXPERIMENTAL
Intervention: AS04-HPV-16/18 vaccine (90% of Arm A and 90% of Arm B girls)
Number of subjects: 34412

Group type: EXPERIMENTAL
Intervention: AS04-HPV-16/18 vaccine (90% of Arm B girls)
Number of subjects: 34412

Group type: EXPERIMENTAL
Intervention: AS04-HPV-16/18 vaccine (in pooled Arms A/B)
Number of subjects: 34412

Group type: COMPARATOR
Intervention: HBV vaccine (10% of Arm A girls and all boys in Arm B, all participants in Arm C)
Number of subjects: 34412
Study: 32034015

Group type: EXPERIMENTAL
Intervention: Balloon pulmonary angioplasty (BPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Riociguat (a soluble guanylate-cyclase stimulator)
Number of subjects: 0
Study: 33715265

Group type: EXPERIMENTAL
Intervention: Late onset dysferlinopathy patients
Number of subjects: 48

Group type: COMPARATOR
Intervention: Early onset dysferlinopathy patients (control group)
Number of subjects: 48
Study: 32280072

Group type: EXPERIMENTAL
Intervention: Fresnel prism glasses with balance and gait training (n=8)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Balance and gait training (n=9)
Number of subjects: 17
Study: 33789010

Group type: EXPERIMENTAL
Intervention: Lumasiran
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 35742702

Group type: EXPERIMENTAL
Intervention: Minimally invasive non-surgical periodontal therapy (MINST)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional non-surgical periodontal therapy (CNST)
Number of subjects: 10
Study: 34866216

Group type: EXPERIMENTAL
Intervention: Fluralaner (oral dose)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 72
Study: 33017529

Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste with 20% baking soda
Number of subjects: 159

Group type: COMPARATOR
Intervention: Fluoride toothpaste control
Number of subjects: 159
Study: 34370994

Group type: EXPERIMENTAL
Intervention: Dacryocystorhinostomy with retrograde intubation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conjunctivo‐dacryocystorhinostomy
Number of subjects: 50
Study: 33124156

Group type: EXPERIMENTAL
Intervention: Artificial dermis combined with autologous split-thickness skin grafting (AD-STSG)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Autologous intermediate-thickness skin grafting (ITSG)
Number of subjects: 56
Study: 32946590

Group type: EXPERIMENTAL
Intervention: XBS + 10 × 10^6 PDL-MSCs/100 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: XBS
Number of subjects: 20
Study: 34538125

Group type: EXPERIMENTAL
Intervention: Traditional bed bath
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disposable bed bath
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both bathing methods
Number of subjects: 0
Study: 33893377

Group type: EXPERIMENTAL
Intervention: myo‐inositol plus α‐lactalbumin plus folic acid
Number of subjects: 120

Group type: COMPARATOR
Intervention: folic acid
Number of subjects: 120
Study: 33267668

Group type: EXPERIMENTAL
Intervention: Handgrip strength test
Number of subjects: 234

Group type: COMPARATOR
Intervention: Standardized muscular strength tests (reference methods)
Number of subjects: 234
Study: 35534312

Group type: EXPERIMENTAL
Intervention: Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with dmLT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fractionated dose of intradermal IPV without dmLT
Number of subjects: 0
Study: 32865597

Group type: EXPERIMENTAL
Intervention: Dulaglutide (weekly for 24 weeks)
Number of subjects: 64
Study: 33731569

Group type: EXPERIMENTAL
Intervention: Calcium hydroxylapatite with lidocaine (3 mL total, 1 to 2 syringes)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Calcium hydroxylapatite (treated side)
Number of subjects: 10
Study: 34156873

Group type: EXPERIMENTAL
Intervention: Home-based telerehabilitation (TR)
Number of subjects: 59

Group type: COMPARATOR
Intervention: In-clinic therapy
Number of subjects: 59
Study: 32819145

Group type: EXPERIMENTAL
Intervention: Conscious Sedation (CS)
Number of subjects: 447

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 447
Study: 34605319

Group type: EXPERIMENTAL
Intervention: Ofatumumab (20 mg every 4 weeks, subcutaneous via autoinjector)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Ofatumumab (20 mg every 4 weeks, subcutaneous via PFS)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: All groups receiving ofatumumab (autoinjector and PFS)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Ofatumumab (both administration methods)
Number of subjects: 256
Study: 32435011

Group type: EXPERIMENTAL
Intervention: Dual lipid‐lowering therapy (DLLT) with ezetimibe and atorvastatin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Atorvastatin monotherapy
Number of subjects: 25
Study: 32770186

Group type: EXPERIMENTAL
Intervention: e-learning module about pain in dementia during a geriatrics course
Number of subjects: 161

Group type: COMPARATOR
Intervention: e-learning module about pain in dementia without the context of a geriatrics course
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control module on pain during a geriatrics course
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Experiential learning (geriatrics course)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Both e-learning and experiential learning
Number of subjects: 161